$ELVR

Elevra Lithium Limited (ASX:ELV) FY26 Full Year Results Announcement

Elevra Lithium (ASX:ELV) reported FY26 results, with revenue up 39% to US$202M. NAL mined 1.47M wmt of ore, producing 197,967 dmt of spodumene concentrate. Unit costs rose 2% to US$853/dmt. The company announced a 15-20% production capacity increase from mid-2027, funded by a US$202M equity raise. Cash balance increased to US$255M.

Original reporting
Published Aug 28, 2026, 4:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 4:15 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Elevra Lithium Limited (ASX:ELV) FY26 Full Year Results Announcement — source image
Decision brief

The 30-second read

$ELVRBullishMed
01

Why it matters

The earnings release confirms the merger synergies and funding of expansion, indicating a stronger balance sheet but also operational challenges.

02

Market read

First‑time FY26 earnings provide fresh data on Elevra's post‑merger performance, influencing lithium sector sentiment.

03

What to watch

The $202M equity raise dilutes existing shareholders and may affect valuation.

Relevance 7/10Novelty 7/10Timing: FY26 full year results announced today

Background

Elevra Lithium recently completed the merger of Sayona Mining and Piedmont Lithium, creating a larger North American lithium producer.

Company-level read

Ticker impact

$ELVRBullishMedium confidence
Context

Elevra Lithium disclosed FY26 full year results with revenue up 39% to $202M and EBITDA turning positive, a fresh earnings release.

Expected impact

Potential modest price appreciation over the next few days, especially if guidance remains upbeat.

Evidence & confidence

Revenue growth and cash strength are material for a junior lithium producer; however, lower production volumes and higher costs temper the upside.

Market effects

Lithium sector may see renewed interest as a major producer reports strong pricing and cash generation.

Positive for Australian and North American lithium supply outlook.

Supports broader demand narrative for battery metals amid EV growth.

Counterpoint

Higher operating costs and lower production volumes could limit upside; investors may wait for FY27 guidance.

Key entities

  • Lucas Dow

    Managing Director and CEO of Elevra Lithium

Related articles

$ELVRMed

Elevra Lithium Announces NAL Expansion Pre-Feasibility Study

Elevra Lithium (ASX:ELV; NASDAQ:ELVR) announced a Pre-Feasibility Study for its North American Lithium (NAL) expansion in Québec. The study projects increased annual spodumene concentrate production to 373ktpa, reduced unit costs, and a post-tax NPV of C$3,218M. The expansion is fully funded with C$366M in initial CAPEX and will be delivered in three stages, starting mid-2027.

$ELVRMed

Elevra Lithium Ltd (ASX:ELV) Corporate Presentation - Outlines Growth Strategy for North American Lithium Platform

Elevra Lithium Ltd (ASX:ELV) outlined its growth strategy for North American Lithium (NAL) in Quebec, targeting 373,000 tonnes of spodumene concentrate annually. FY26 production was 197,967 tonnes, with revenue of US$202 million. The company plans a three-stage expansion, with initial capital expenditure of US$271 million. FY27 production guidance is 198,000 to 210,000 tonnes.

$ELVRMed

Elevra Lithium Ltd (ASX:ELV) NAL Expansion Pre-Feasibility Study

Elevra Lithium (ASX:ELV, NASDAQ:ELVR) announced a Pre-Feasibility Study for its North American Lithium (NAL) expansion, targeting increased spodumene production and reduced costs. The project, fully funded at C$366M, aims to boost annual output to 373ktpa by mid-2029, with a post-tax NPV of C$3.218B. The expansion is expected to reduce LOM C1 costs to C$851/t post-expansion, according to the company.

$ELVRMed

Elevra Lithium H2 Earnings Call Highlights

Elevra Lithium reported cash of $255M at June 30, up from $47M a year earlier, with additional funding from convertible notes. NAL produced 198,000 tonnes of spodumene concentrate, down 3% YoY. Expansion plans include increasing milling capacity to 6,500 tonnes per day, with stage one expected by mid-2027. Fiscal 2027 guidance includes production of 198,000-210,000 tonnes and unit costs of $880-$950 per tonne.

$ELVRMed

Elevra Lithium Ltd (ASX:ELV) Binding Agreement Concluded with Mangrove Lithium

Elevra Lithium (ASX:ELV) has signed a binding 7-year spodumene supply agreement with Mangrove Lithium, extendable for another 7 years. The deal secures long-term local supply for Elevra's Quebec operations at market-linked prices with downside protection. Mangrove's facility, pending financing, will avoid Elevra's ocean freight costs. Both companies are backed by Canada Growth Fund.

$ELVRMed

Elevra Lithium Completes Binding Supply Agreement with Mangrove Lithium

Elevra Lithium (ASX:ELV, NASDAQ:ELVR) finalized a binding supply agreement with Mangrove Lithium for long-term spodumene concentrate supply from its North American Lithium facility in Québec. The deal follows a previous MoU and includes a price floor above production costs and no price ceiling. Elevra aims to avoid seaborne freight costs by supplying a local customer.